Cargando…
Diabetes, cardiovascular disease and the microcirculation
Cardiovascular disease (CVD) is the leading cause of mortality in people with type 2 diabetes mellitus (T2DM), yet a significant proportion of the disease burden cannot be accounted for by conventional cardiovascular risk factors. Hypertension occurs in majority of people with T2DM, which is substan...
Autores principales: | Strain, W. David, Paldánius, P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905152/ https://www.ncbi.nlm.nih.gov/pubmed/29669543 http://dx.doi.org/10.1186/s12933-018-0703-2 |
Ejemplares similares
-
Correction to: Diabetes, cardiovascular disease and the microcirculation
por: Strain, W. David, et al.
Publicado: (2021) -
Microcirculation and Cardiovascular Diseases
por: Tibiriçá, Eduardo, et al.
Publicado: (2018) -
Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017) -
Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?
por: Strain, William David, et al.
Publicado: (2014) -
Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease?
por: Rizzoni, Damiano, et al.
Publicado: (2023)